Human Cytomegalovirus Induces the Expression of the AMPKa2 Subunit to Drive Glycolytic Activation and Support Productive Viral Infection

Human Cytomegalovirus Induces the Expression of the AMPKa2 Subunit to Drive Glycolytic Activation and Support Productive Viral Infection

The human cytomegalovirus infection (HCMV) modulates cellular metabolism to support viral replication. Kinase Kinase Kinase Calcium / Calmodulin (CAMKK) and Protein activated amp (AMPK) regulates metabolic activation and has been found important for successful HCMV infections. Here, we explore the specific contributions of camkk isoforms and ampk subunit isoforms to make HCMV infection. Our results show that various ISOFORM camkk and AMPK contribute to infection in a unique way.

For example, Camkk1 is important for HCMV infection in low infection multiplicity, but can be used for AMPK activation during the earliest infection, which is suggested by our data more dependent on camkk2. Our results also show that HCMV specifically induces the expression of catalytic subunit ampka2 non-ubiquitous, which is found important for glycolytic activation mediated by HCMV and high titers infections. Furthermore, we found that glycolytic activation mediated ampk was important for infection, as an excessive expression of glut4, high-capacity glucose transporter, some saved viral replication in the face of the inhibition of Ampk.

Collectively, our data shows that HCMV infection selectively induces specific metabolic regulation kinase expression, relying on their activities to support glycolytic activation and productive infection. The important virus is a mandatory parasite to provide energy and molecular building blocks to the masses to produce a descendant of the infectious virus. The process that regulates the modulation of cellular resource viruses has emerged as critical for successful infections.

Here, we find that HCMV depends on two kinase isoforms to support infection, camkk1 and ampka2. We found that HCMV specifically induces ampka2 subunit expression to induce metabolic activation and encourage strong viral replication. These results indicate that HCMV has evolved a mechanism to target certain metabolic regulatory kinase subunits to support productive infections, thus providing insight into how HCMV hijacked cellular metabolism for replication, and explained the vulnerability of potential virus therapy.

Cytomegalovirus cervical reactivation, cytokine, and spontaneous premature birth in Kenyan women

Activation of cytomegalovirus genital reactivation (CMV) is common during the third trimester of pregnancy. We hypothesize, cervical CMV shedding can increase the risk of spontaneous premature birth (SPTB) through the release of inflammatory cytokines in the cervix. We conducted a nesting case control analysis to determine the relationship between shedding CMV and SPTB using data and samples from prospective cohort studies in West Kenya. Women delivered between 28 + 0 and 33 + 6 weeks of pregnancy are adjusted to the gestational age on the collection of samples to control delivered ≥37 + 0 weeks.

The Level of CMV DNA and Interleukin (IL) -1 Beta (β), IL-6, IL-8, and Necrosis Factor-Alpha (TNF-α) tumors are measured in the servix. We use conditional logistic regression to assess the relationship between shedding cmv, cervical cytokine levels, and SPTB. Among the 86 cases and 86 suitable controls, cmv cervical levels are not significantly related to the SPTB (Odds Ratio [or] = 1.23, 95% trust interval [CI] 0.59-2.56), but significantly associated With higher IL-6 cervical levels. (β = 0.15, 95% CI 0.02-0.29) and TNF-α (β = 0.14, 95% CI 0.01-0.27). In univariate analysis, higher SPTB opportunities are associated with higher cervical IL-6 levels (or = 1.54, 95% CI 1.00-2.38), but not with other cervical cytokines. In this Kenyan women’s cohort, we did not find a significant relationship between cervical and SPTB shedding before 34 weeks.

Letermovir prophylaxis is effective in preventing reactivation of cytomegalovirus after alogenic hematopoietic cell transplantation: real single world data data

Morbidity and mortality after alogenic hematopoietic cell transplants (ALLOHCT) are still basically influenced by Cytomegalovirus (CMV) reactivation. We evaluate 80 seropositive patients transplanted in a row between March 2018 and March 2019 who received the prophylaxis of the Letermovir (leave) from engraftment to day +100 and retrospectively compare it with 80 patients without allowing allograft between January 2017 and March 2018.

The end point of research This is a cumulative incidence (CI) Clinically significant CMV infection (CS-CMVI) defined as CMV reactivation which demands preemptive treatment or CMV disease. With 14% CI CS-CMVI on the day +100 (11 events) significantly lower in let the cohort compared to the control group (33 events, 41%; HR 0.29; p <0.001). While therapy with Foscarnet can be fully avoided in the Group Leave, 7 out of 80 patients in the control cohort receiving Foscarnet, producing 151 extra patients for foscarnet (p = 0.002). The overall survival of one year is 72% on the control arm vs. 84% in the arms (HR 0.75 [95% CI 0.43-1.30]; P <0.306). This study confirms the efficacy and security let’s for the CS-CMVI prophylaxis after ALLOHCT in real-world settings, resulting in significant patient benefits by reducing hospitalization needs and exposure to antivirus drugs that are potentially toxic for the treatment of CMV reactivation.

Human Cytomegalovirus Induces the Expression of the AMPKa2 Subunit to Drive Glycolytic Activation and Support Productive Viral Infection

Micrornas screening and validation and targets expressly expressed in hypertensive mice caused by cytomegalovirus infection

Introduction Some studies have suggested the relationship between Cytomegalovirus (CMV) infection and essential hypertension (eh). Micrornas (MIRNAS) plays an important role in developing EH by regulating specific target gene expression. However, a few are known about the role of MIRNA in uh induced by CMV. In this study, we compare the profile of Mirna’s expressions from samples from normal and murine cytomegalovirus (MCMV) -Infected C57BL / 6 mice using high-throughput sequencing analysis.

The method we collect thoracic aortic, heart tissue, and peripheral blood of twenty normal mice and twenty mice infected with MCMV. We identify Mirna which is expressly expressed in peripheral blood samples and predicts their target genes using bioinformatics tools. We then experimentally validated them using QRT-PCR and target genes with a double luciferase gene test test. The results we found 118 expressed by MIRNAs, including 9 MIRNAs was identified as potential hypertensive regulators induced by MCMV infection. We then validated the expression of two MIRAS candidates, MMU-MIR-1929-3P and MCMV-MIR-M01-4-5P, using QRT-PCR.

FBXO17 Antibody - N-terminal region

MBS3217540-01mL 0.1mL
EUR 455

FBXO17 Antibody - N-terminal region

MBS3217540-5x01mL 5x0.1mL
EUR 1995

F-Box Protein 17 (FBXO17) Antibody

abx233038-100ug 100 ug
EUR 577.2

F-Box Protein 17 (FBXO17) Antibody

abx233038-100g 100 µg
EUR 350

ARP67585_P050-25UL - FBXO17 Antibody - N-terminal region

ARP67585_P050-25UL 25ul
EUR 99

ARP67585_P050 - FBXO17 Antibody - N-terminal region (ARP67585_P050)

ARP67585_P050 100ul
EUR 389

FBXO17

CSB-CL853409HU 10 μg plasmid + 200μl Glycerol Ask for price

FBXO17

MBS8563971-01mLAF405L 0.1mL(AF405L)
EUR 565

FBXO17

MBS8563971-01mLAF405S 0.1mL(AF405S)
EUR 565

FBXO17

MBS8563971-01mLAF610 0.1mL(AF610)
EUR 565

FBXO17

MBS8563971-01mLAF635 0.1mL(AF635)
EUR 565

FBXO17

MBS8563971-02mL 0.2mL
EUR 345

FBXO17 siRNA

20-abx916592
  • Ask for price
  • Ask for price
  • 15 nmol
  • 30 nmol

FBXO17 siRNA

20-abx916593
  • Ask for price
  • Ask for price
  • 15 nmol
  • 30 nmol

FBXO17 siRNA

20-abx901910
  • Ask for price
  • Ask for price
  • 15 nmol
  • 30 nmol

Fbxo17 (untagged) - Mouse F-box protein 17 (Fbxo17), (10ug)

MC209863 10 µg Ask for price

FBXO17 siRNA (Rat)

MBS8219173-15nmol 15nmol
EUR 405

FBXO17 siRNA (Rat)

MBS8219173-30nmol 30nmol
EUR 565

FBXO17 siRNA (Rat)

MBS8219173-5x30nmol 5x30nmol
EUR 2450

FBXO17 cDNA Clone

MBS1275537-001mgPlasmid02mLGlycerolStock 0.01mgPlasmid+0.2mLGlycerol-Stock
EUR 300

FBXO17 cDNA Clone

MBS1275537-5x001mgPlasmid5x02mLGlycerolStock 5x0.01mgPlasmid+5x0.2mLGlycerol-Stock
EUR 1300

FBXO17 siRNA (Mouse)

MBS8203339-15nmol 15nmol
EUR 405

FBXO17 siRNA (Mouse)

MBS8203339-30nmol 30nmol
EUR 565

FBXO17 siRNA (Mouse)

MBS8203339-5x30nmol 5x30nmol
EUR 2450

FBXO17 siRNA (Human)

MBS8215045-15nmol 15nmol
EUR 405

FBXO17 siRNA (Human)

MBS8215045-30nmol 30nmol
EUR 565

FBXO17 siRNA (Human)

MBS8215045-5x30nmol 5x30nmol
EUR 2450

FBXO17 cloning plasmid

CSB-CL853409HU-10ug 10ug
EUR 411.6
Description: A cloning plasmid for the FBXO17 gene.

FBXO17 Blocking Peptide

DF13006-BP 1mg
EUR 234

FBXO17 Blocking Peptide

MBS9621710-1mg 1mg
EUR 380

FBXO17 Blocking Peptide

MBS9621710-5x1mg 5x1mg
EUR 1650

Recombinant Human FBXO17

MBS7615987-005mg 0.05mg
EUR 405

Recombinant Human FBXO17

MBS7615987-02mg 0.2mg
EUR 760

Recombinant Human FBXO17

MBS7615987-1mg 1mg
EUR 2175

Recombinant Human FBXO17

MBS7615987-5x1mg 5x1mg
EUR 8410

Fbxo17 (Myc-DDK-tagged) - Mouse F-box protein 17 (Fbxo17)

MR203902 10 µg Ask for price

Fbxo17 (untagged ORF) - Rat F-box protein 17 (Fbxo17), (10 ug)

RN206465 10 µg Ask for price

Rat Fbxo17 ELISA Kit

ELI-47403r 96tests
EUR 756

FBXO17 (untagged)-Human F-box protein 17 (FBXO17), transcript variant 2

SC323757 10 µg Ask for price

FBXO17 (untagged)-Human F-box protein 17 (FBXO17), transcript variant 1

SC310570 10 µg Ask for price

Human FBXO17 ELISA KIT

EF009580 96tests
EUR 566

Rat FBXO17 shRNA Plasmid

20-abx988576
  • Ask for price
  • Ask for price
  • 150 µg
  • 300 µg

Mouse FBXO17 shRNA Plasmid

20-abx974104
  • Ask for price
  • Ask for price
  • 150 µg
  • 300 µg

Human FBXO17 shRNA Plasmid

20-abx964438
  • Ask for price
  • Ask for price
  • 150 µg
  • 300 µg

Human FBXO17 Protein Lysate

MBS8411631-002mg 0.02mg
EUR 365

Human FBXO17 Protein Lysate

MBS8411631-5x002mg 5x0.02mg
EUR 1410

FBXO17 Recombinant Protein (Rat)

RP200984 100 ug Ask for price

FBXO17 (GFP-tagged) - Human F-box protein 17 (FBXO17), transcript variant 1

RG222996 10 µg Ask for price

FBXO17 (GFP-tagged) - Human F-box protein 17 (FBXO17), transcript variant 2

RG202158 10 µg Ask for price

FBXO17 Recombinant Protein (Human)

RP011875 100 ug Ask for price

FBXO17 Recombinant Protein (Mouse)

RP133955 100 ug Ask for price

Fbxo17 (Myc-DDK-tagged ORF) - Rat F-box protein 17 (Fbxo17), (10 ug)

RR206465 10 µg Ask for price

anti- FBXO18 antibody

FNab03039 100µg
EUR 658.5
Description: Antibody raised against FBXO18

anti- FBXO22 antibody

FNab03041 100µg
EUR 702
Description: Antibody raised against FBXO22

anti- FBXO28 antibody

FNab03042 100µg
EUR 702
Description: Antibody raised against FBXO28

anti- FBXO32 antibody

FNab03044 100µg
EUR 606.3
Description: Antibody raised against FBXO32

anti- FBXO41 antibody

FNab03045 100µg
EUR 658.5
Description: Antibody raised against FBXO41

anti- FBXO43 antibody

FNab03046 100µg
EUR 702
Description: Antibody raised against FBXO43

Lenti ORF clone of Fbxo17 (mGFP-tagged) - Mouse F-box protein 17 (Fbxo17)

MR203902L4 10 µg Ask for price

FBXO17 (Myc-DDK-tagged)-Human F-box protein 17 (FBXO17), transcript variant 2

RC202158 10 µg Ask for price

FBXO17 (Myc-DDK-tagged)-Human F-box protein 17 (FBXO17), transcript variant 1

RC222996 10 µg Ask for price

Fbxo17 ORF Vector (Rat) (pORF)

ORF066996 1.0 ug DNA
EUR 607.2

Fbxo17 ORF Vector (Mouse) (pORF)

ORF044653 1.0 ug DNA
EUR 607.2

FBXO17 ORF Vector (Human) (pORF)

ORF003959 1.0 ug DNA
EUR 114

anti- FBXO2 antibody

FNab03040 100µg
EUR 606.3
Description: Antibody raised against FBXO2

anti- FBXO3 antibody

FNab03043 100µg
EUR 606.3
Description: Antibody raised against FBXO3

anti- FBXO5 antibody

FNab03047 100µg
EUR 658.5
Description: Antibody raised against FBXO5

anti- FBXO6 antibody

FNab03048 100µg
EUR 606.3
Description: Antibody raised against FBXO6

anti- FBXO7 antibody

FNab03049 100µg
EUR 702
Description: Antibody raised against FBXO7

anti- FBXO8 antibody

FNab03050 100µg
EUR 658.5
Description: Antibody raised against FBXO8

anti- FBXO9 antibody

FNab03051 100µg
EUR 658.5
Description: Antibody raised against FBXO9

Lenti ORF clone of Fbxo17 (Myc-DDK-tagged) - Mouse F-box protein 17 (Fbxo17)

MR203902L3 10 µg Ask for price

Human FBXO17 knockout cell line

ABC-KH5399 1 vial Ask for price
Description: Human FBXO17 knockout cell line is HEK293/HeLa cell line, edited by CRISPR/Cas9 technology.

Human FBXO17 knockdown cell line

ABC-KD5399 1 vial Ask for price
Description: Human FBXO17 knockdown cell line is engineered by our optimized transduction of the specific shRNA with lentivirus. Knockdown levels are determined via qRT-PCR. Gentaur offers generation of stable knockdown (RNAi) cell lines expressing shRNAs targeting genes of your interest.

Human FBXO17 Protein Lysate 20ug

IHUFBXO17PLLY20UG each
EUR 213
Description: Human FBXO17 Protein Lysate 20ug

FBXO17 Peptide - N-terminal region

MBS3242435-01mg 0.1mg
EUR 180

FBXO17 Peptide - N-terminal region

MBS3242435-5x01mg 5x0.1mg
EUR 730

Anti-LMO7 / FBXO20 antibody

STJ70480 100 µg
EUR 430.8

Recombinant Human FBXO17, His-tagged

FBXO17-12786H 25ug
EUR 255.2
Description: The protein is stored in PBS buffer at -20℃. Avoid repeated freezing and thawing cycles.

OCOA08123-20UG - FBXO17 Protein Lysate

OCOA08123-20UG 20ug
EUR 169

OCOA05907-20UG - FBXO17 Protein Lysate

OCOA05907-20UG 20ug
EUR 169

FBXO17 Over-expression Lysate Product

GWB-6BC062 0.1 mg Ask for price

FBXO17 (NM_148169) Human Over-expression Lysate

LS115290 100ug
EUR 628
Description: Transient overexpression lysate of F-box protein 17 (FBXO17), transcript variant 1

Lenti ORF clone of Fbxo17 (mGFP-tagged ORF) - Rat F-box protein 17 (Fbxo17), (10 ug)

RR206465L4 10 µg Ask for price

Goat anti-LMO7 / FBXO20 Antibody

dAP-0271 50ug
EUR 264.6

Goat anti-LMO7/FBXO20 Antibody

MBS421148-01mg 0.1mg
EUR 400

Goat anti-LMO7/FBXO20 Antibody

MBS421148-5x01mg 5x0.1mg
EUR 1660

Lenti ORF particles, Fbxo17 (GFP-tagged) - Mouse F-box protein 17 (Fbxo17), 200ul, >10^7 TU/mL

MR203902L4V 200 µl Ask for price

Lenti ORF clone of Fbxo17 (Myc-DDK-tagged ORF) - Rat F-box protein 17 (Fbxo17), (10 ug)

RR206465L3 10 µg Ask for price

Fbxo17 sgRNA CRISPR Lentivector set (Rat)

K6558001 3 x 1.0 ug
EUR 406.8

FBXO17 sgRNA CRISPR Lentivector set (Human)

K0764701 3 x 1.0 ug
EUR 406.8

Fbxo17 sgRNA CRISPR Lentivector set (Mouse)

K4857601 3 x 1.0 ug
EUR 406.8

Lenti ORF particles, Fbxo17 (GFP-tagged ORF) - Rat F-box protein 17 (Fbxo17), 200ul, >10^7 TU/mL

RR206465L4V 200 µl Ask for price

Lenti ORF particles, Fbxo17 (Myc-DDK-tagged) - Mouse F-box protein 17 (Fbxo17), 200ul, >10^7 TU/mL

MR203902L3V 200 µl Ask for price

FBXO17 3'UTR GFP Stable Cell Line

TU057783 1.0 ml
EUR 2799.6

Fbxo17 3'UTR GFP Stable Cell Line

TU254497 1.0 ml Ask for price

Fbxo17 3'UTR GFP Stable Cell Line

TU156413 1.0 ml Ask for price

FBXO17 Protein Vector (Rat) (pPM-C-HA)

PV267984 500 ng
EUR 723.6

Lenti ORF particles, Fbxo17 (Myc-DDK-tagged ORF) - Rat F-box protein 17 (Fbxo17), 200ul, >10^7 TU/mL

RR206465L3V 200 µl Ask for price

FBXO17 Protein Vector (Rat) (pPB-C-His)

PV267982 500 ng
EUR 723.6

FBXO17 Protein Vector (Rat) (pPB-N-His)

PV267983 500 ng
EUR 723.6

FBXO17 Protein Vector (Rat) (pPM-C-His)

PV267985 500 ng
EUR 723.6

FBXO17 Protein Vector (Human) (pPM-C-HA)

PV015835 500 ng
EUR 394.8

FBXO17 Protein Vector (Mouse) (pPM-C-HA)

PV178612 500 ng
EUR 723.6

Fbxo17 3'UTR Luciferase Stable Cell Line

TU204497 1.0 ml Ask for price

FBXO17 3'UTR Luciferase Stable Cell Line

TU007783 1.0 ml
EUR 2799.6

FBXO17 Protein Vector (Human) (pPB-C-His)

PV015833 500 ng
EUR 394.8

FBXO17 Protein Vector (Human) (pPB-N-His)

PV015834 500 ng
EUR 394.8

FBXO17 Protein Vector (Human) (pPM-C-His)

PV015836 500 ng
EUR 394.8

FBXO17 Protein Vector (Mouse) (pPB-C-His)

PV178610 500 ng
EUR 723.6

FBXO17 Protein Vector (Mouse) (pPB-N-His)

PV178611 500 ng
EUR 723.6

FBXO17 Protein Vector (Mouse) (pPM-C-His)

PV178613 500 ng
EUR 723.6

Fbxo17 3'UTR Luciferase Stable Cell Line

TU106413 1.0 ml Ask for price

Fbxo17 sgRNA CRISPR Lentivector (Rat) (Target 1)

K6558002 1.0 ug DNA
EUR 184.8

Fbxo17 sgRNA CRISPR Lentivector (Rat) (Target 2)

K6558003 1.0 ug DNA
EUR 184.8

Fbxo17 sgRNA CRISPR Lentivector (Rat) (Target 3)

K6558004 1.0 ug DNA
EUR 184.8

FBXO17 sgRNA CRISPR Lentivector (Human) (Target 1)

K0764702 1.0 ug DNA
EUR 184.8

FBXO17 sgRNA CRISPR Lentivector (Human) (Target 2)

K0764703 1.0 ug DNA
EUR 184.8

FBXO17 sgRNA CRISPR Lentivector (Human) (Target 3)

K0764704 1.0 ug DNA
EUR 184.8

Fbxo17 sgRNA CRISPR Lentivector (Mouse) (Target 1)

K4857602 1.0 ug DNA
EUR 184.8

Fbxo17 sgRNA CRISPR Lentivector (Mouse) (Target 2)

K4857603 1.0 ug DNA
EUR 184.8

Fbxo17 sgRNA CRISPR Lentivector (Mouse) (Target 3)

K4857604 1.0 ug DNA
EUR 184.8

OAEB01801-100UG - Goat Anti-LMO7 / FBXO20 Antibody

OAEB01801-100UG 100ug
EUR 349

Mouse monoclonal antibody Anti-Human FBXO18

MBS120373-01mg 0.1mg
EUR 470

Mouse monoclonal antibody Anti-Human FBXO18

MBS120373-5x01mg 5x0.1mg
EUR 2080

Rat F-Box Protein 17 (FBXO17) ELISA Kit

abx523611-96tests 96 tests
EUR 687.5

AAP67585-100UG - FBXO17 Peptide - N-terminal region

AAP67585-100UG 100ug
EUR 99

Human F-Box Protein 17 (FBXO17) ELISA Kit

abx387316-96tests 96 tests
EUR 1093.2

Lenti ORF particles, FBXO17 (mGFP-tagged) - Human F-box protein 17 (FBXO17), transcript variant 2, 200ul, >10^7 TU/mL

RC202158L4V 200 µl Ask for price

Lenti ORF particles, FBXO17 (mGFP-tagged) - Human F-box protein 17 (FBXO17), transcript variant 1, 200ul, >10^7 TU/mL

RC222996L2V 200 µl Ask for price

Lenti ORF particles, FBXO17 (mGFP-tagged) - Human F-box protein 17 (FBXO17), transcript variant 1, 200ul, >10^7 TU/mL

RC222996L4V 200 µl Ask for price

Recombinant Rat F-box only protein 17 (Fbxo17)

MBS1485150-002mgBaculovirus 0.02mg(Baculovirus)
EUR 1130

Recombinant Rat F-box only protein 17 (Fbxo17)

MBS1485150-002mgEColi 0.02mg(E-Coli)
EUR 760

Recombinant Rat F-box only protein 17 (Fbxo17)

MBS1485150-002mgYeast 0.02mg(Yeast)
EUR 920

Recombinant Rat F-box only protein 17 (Fbxo17)

MBS1485150-01mgEColi 0.1mg(E-Coli)
EUR 915

Recombinant Rat F-box only protein 17 (Fbxo17)

MBS1485150-01mgYeast 0.1mg(Yeast)
EUR 1080

Recombinant Human F-box only protein 17 (FBXO17)

MBS1476384-002mgBaculovirus 0.02mg(Baculovirus)
EUR 1160

Recombinant Human F-box only protein 17 (FBXO17)

MBS1476384-002mgEColi 0.02mg(E-Coli)
EUR 795

Recombinant Human F-box only protein 17 (FBXO17)

MBS1476384-002mgYeast 0.02mg(Yeast)
EUR 945

Recombinant Human F-box only protein 17 (FBXO17)

MBS1476384-01mgEColi 0.1mg(E-Coli)
EUR 955

Recombinant Human F-box only protein 17 (FBXO17)

MBS1476384-01mgYeast 0.1mg(Yeast)
EUR 1110

Recombinant Mouse F-box only protein 17 (Fbxo17)

MBS1457891-002mgBaculovirus 0.02mg(Baculovirus)
EUR 1165

Recombinant Mouse F-box only protein 17 (Fbxo17)

MBS1457891-002mgEColi 0.02mg(E-Coli)
EUR 805

Recombinant Mouse F-box only protein 17 (Fbxo17)

MBS1457891-002mgYeast 0.02mg(Yeast)
EUR 955

Recombinant Mouse F-box only protein 17 (Fbxo17)

MBS1457891-01mgEColi 0.1mg(E-Coli)
EUR 965

Recombinant Mouse F-box only protein 17 (Fbxo17)

MBS1457891-01mgYeast 0.1mg(Yeast)
EUR 1120

Recombinant Rat FBXO17 Protein, His (Fc)-Avi-tagged

FBXO17-1946R 50ug
EUR 2398.4
Description: For long term storage, aliquot and store at -20 to -80 centigrade. Avoid repeated freezing and thawing cycles.

Lenti ORF particles, FBXO17 (Myc-DDK tagged) - Human F-box protein 17 (FBXO17), transcript variant 2, 200ul, >10^7 TU/mL

RC202158L3V 200 µl Ask for price

Lenti ORF particles, FBXO17 (Myc-DDK tagged) - Human F-box protein 17 (FBXO17), transcript variant 1, 200ul, >10^7 TU/mL

RC222996L1V 200 µl Ask for price

Lenti ORF particles, FBXO17 (Myc-DDK tagged) - Human F-box protein 17 (FBXO17), transcript variant 1, 200ul, >10^7 TU/mL

RC222996L3V 200 µl Ask for price

FBXO17 Lentiviral Vector (Rat) (CMV) (pLenti-GIII-CMV)

LV665293 1.0 ug DNA
EUR 616.8

FBXO17 Lentiviral Vector (Rat) (UbC) (pLenti-GIII-UbC)

LV665297 1.0 ug DNA
EUR 616.8

Rat F box only protein 17(FBXO17) ELISA kit

E02F0279-192T 192 tests
EUR 1524
Description: A competitive ELISA for quantitative measurement of Rat F box only protein 17(FBXO17) in samples from blood, plasma, serum, cell culture supernatant and other biological fluids. This is a high quality ELISA kit developped for optimal performance with samples from the particular species.

Rat F box only protein 17(FBXO17) ELISA kit

E02F0279-48 1 plate of 48 wells
EUR 624
Description: A competitive ELISA for quantitative measurement of Rat F box only protein 17(FBXO17) in samples from blood, plasma, serum, cell culture supernatant and other biological fluids. This is a high quality ELISA kit developped for optimal performance with samples from the particular species.

Rat F box only protein 17(FBXO17) ELISA kit

E02F0279-96 1 plate of 96 wells
EUR 822
Description: A competitive ELISA for quantitative measurement of Rat F box only protein 17(FBXO17) in samples from blood, plasma, serum, cell culture supernatant and other biological fluids. This is a high quality ELISA kit developped for optimal performance with samples from the particular species.

Pig F box only protein 17(FBXO17) ELISA kit

E07F0279-192T 192 tests
EUR 1524
Description: A competitive ELISA for quantitative measurement of Porcine F box only protein 17(FBXO17) in samples from blood, plasma, serum, cell culture supernatant and other biological fluids. This is a high quality ELISA kit developped for optimal performance with samples from the particular species.

Pig F box only protein 17(FBXO17) ELISA kit

E07F0279-48 1 plate of 48 wells
EUR 624
Description: A competitive ELISA for quantitative measurement of Porcine F box only protein 17(FBXO17) in samples from blood, plasma, serum, cell culture supernatant and other biological fluids. This is a high quality ELISA kit developped for optimal performance with samples from the particular species.

Pig F box only protein 17(FBXO17) ELISA kit

E07F0279-96 1 plate of 96 wells
EUR 822
Description: A competitive ELISA for quantitative measurement of Porcine F box only protein 17(FBXO17) in samples from blood, plasma, serum, cell culture supernatant and other biological fluids. This is a high quality ELISA kit developped for optimal performance with samples from the particular species.

Dog F box only protein 17(FBXO17) ELISA kit

E08F0279-192T 192 tests
EUR 1524
Description: A competitive ELISA for quantitative measurement of Canine F box only protein 17(FBXO17) in samples from blood, plasma, serum, cell culture supernatant and other biological fluids. This is a high quality ELISA kit developped for optimal performance with samples from the particular species.

Dog F box only protein 17(FBXO17) ELISA kit

E08F0279-48 1 plate of 48 wells
EUR 624
Description: A competitive ELISA for quantitative measurement of Canine F box only protein 17(FBXO17) in samples from blood, plasma, serum, cell culture supernatant and other biological fluids. This is a high quality ELISA kit developped for optimal performance with samples from the particular species.

Dog F box only protein 17(FBXO17) ELISA kit

E08F0279-96 1 plate of 96 wells
EUR 822
Description: A competitive ELISA for quantitative measurement of Canine F box only protein 17(FBXO17) in samples from blood, plasma, serum, cell culture supernatant and other biological fluids. This is a high quality ELISA kit developped for optimal performance with samples from the particular species.

Rat F box only protein 17(FBXO17) ELISA kit

E01A13263 96T
EUR 700
Description: ELISA

FBXO17 Lentiviral Vector (Rat) (EF1a) (pLenti-GIII-EF1a)

LV665298 1.0 ug DNA
EUR 616.8

Goat F box only protein 17(FBXO17) ELISA kit

E01A48172 96T
EUR 700
Description: ELISA

Goat F box only protein 17(FBXO17) ELISA kit

E06F0279-192T 192 tests
EUR 1524
Description: A competitive ELISA for quantitative measurement of Goat F box only protein 17(FBXO17) in samples from blood, plasma, serum, cell culture supernatant and other biological fluids. This is a high quality ELISA kit developped for optimal performance with samples from the particular species.

Goat F box only protein 17(FBXO17) ELISA kit

E06F0279-48 1 plate of 48 wells
EUR 624
Description: A competitive ELISA for quantitative measurement of Goat F box only protein 17(FBXO17) in samples from blood, plasma, serum, cell culture supernatant and other biological fluids. This is a high quality ELISA kit developped for optimal performance with samples from the particular species.

Furthermore, the dual-luciferase reporter gene test revealed that the area 3′-untranslated (UTR) endothelin A receptor (Ednra) MRNA contains a binding site for MMU-MIR-1929-3P. Collectively, our data shows that MCMV infection can increase blood pressure and reduce MMU-MIR-1929-3P expression in C57BL / 6. In addition, we find that MMU-MIR-1929-3P targets 3 ‘UTR from MRNA Ednra. Conclusion This new regulation axis can help develop a new approach to clinical prevention and control eh.

Leave A Comment